Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid

Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid

Saved in:

Bibliographic Details
Main Authors:	Kyohei Shibuta, Koremasa Hayama, Katsuhiro Miura, Hideki Fujita
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Journal of Cutaneous Immunology and Allergy
Subjects:	pyoderma gangrenosum myelofibrosis adalimumab ruxolitinib Janus Kinase 2
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14079/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline
by: Hanlin Zhang, et al.
Published: (2025-12-01)

Successful management of pyoderma gangrenosum after caesarean section: a case report
by: Liqin Yang, et al.
Published: (2024-12-01)

Diagnostic Dilemma of Leukemoid Reaction in Pediatric Pyoderma Gangrenosum
by: Snehal Umesh Chopade, et al.
Published: (2024-12-01)

Pyoderma Gangrenosum: A Nightmare for Breast Surgery-Two Case Reports
by: Gülşen Akoğlu, et al.
Published: (2025-01-01)

Bullous Pyoderma Gangrenosum Associated with Antiphospholipid Syndrome: A Case Report and Literature Review
by: Yousuf Alwashahi, et al.
Published: (2024-07-01)

PASS Syndrome: Clinical Observation
by: Olga Valentinovna Grabovskaya, et al.
Published: (2025-01-01)

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
by: Liu J, et al.
Published: (2025-02-01)

Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis
by: Mariarita Spampinato, et al.
Published: (2025-01-01)

Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis
by: Grace Xiong, BHSc, et al.
Published: (2025-04-01)

Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa
by: Zahidul Islam, BA, et al.
Published: (2025-02-01)

Adalimumab-induced optic neuropathy in a patient with Behçet’s syndrome
by: Sofia Miranda, et al.
Published: (2025-01-01)

Analysis of MicroRNA -155-5p Expression in Patients with Primary Myelofibrosis.
by: Sarah I. Khaleel, et al.
Published: (2024-12-01)

Tuberculosis of the tongue in a patient under treatment with adalimumab
by: Cintia Mussi Milani, et al.
Published: (2024-12-01)

The global, regional, and national patterns of change in the burden of bacterial pyoderma from 1990 to 2019 and the forecast for the next decade
by: Hao Wang, et al.
Published: (2025-01-01)

Pyoderma gangrenosum. A case report
by: Elizabet Fernández López, et al.
Published: (2023-02-01)

Peripheral Ulcerative Keratitis with Pyoderma Gangrenosum
by: Adrián Imbernón-Moya, et al.
Published: (2015-01-01)

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
by: Edyta Szymanska, et al.
Published: (2016-12-01)

Successful Treatment of Annular Atrophic Lichen Planus With Adalimumab
by: Joe Khodeir, et al.
Published: (2025-01-01)

Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial
by: Graham McIlroy, et al.
Published: (2025-01-01)

Size exclusion chromatography as green support for forced degradation study of adalimumab
by: Kovačić Jelena, et al.
Published: (2023-12-01)

Screening for Janus kinase-2 exon 12 mutations among Janus kinase-2 V617F-negative polycythemia vera suspected Iraqi patients
by: Mushtaq M. Khazeem, et al.
Published: (2024-12-01)

Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review
by: Erin Balay-Dustrude, et al.
Published: (2024-12-01)

Efficacy of adalimumab in pediatric non-infectious uveitis with and without anterior segment inflammation
by: Chunbo Zhang, et al.
Published: (2025-01-01)

The Efficacy of Adalimumab Treatment in Pediatric Non-Infectious Uveitis: A Retrospective Cohort Study
by: Kübra Özdemir Yalçınsoy, et al.
Published: (2024-12-01)

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01)

Erythema Nodosum and Pyoderma Gangrenosum in 50 Patients with Crohn’s Disease
by: Hugh J Freeman
Published: (2005-01-01)

Pyoderma Gangrenosum in Two Successive Pregnancies Complicating Caesarean Wound
by: Sapna Vinit Amin, et al.
Published: (2014-01-01)

Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01)

Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity
by: Aboli Bhingarkar, et al.
Published: (2025-01-01)

Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01)

Efficacy of adalimumab for Hailey-Hailey disease demonstrated by reduction of the Pemphigus Disease Area Index
by: Madeleine Stark, MChD, et al.
Published: (2025-02-01)

Case report: dysgeusia, strawberry tongue, and psoriatic eruptions after combination treatment with adalimumab, sulfasalazine, and etoricoxib for ankylosing spondylitis
by: Binglin Cui, et al.
Published: (2025-02-01)

Large Pyoderma Gangrenosum-Like Ulcers: A Rare Presentation of Granulomatosis with Polyangiitis
by: Basheer Tashtoush, et al.
Published: (2014-01-01)

Pyoderma Gangrenosum following Pacemaker Implantation: A Case Report and Review of Literature
by: Noura Ayoubi, et al.
Published: (2019-01-01)

Pyoderma Gangrenosum Mimicking an Infected Wound following Dynamic Hip Screw Fixation
by: Metin Nizamoglu
Published: (2015-01-01)

Treatment Considerations for Pyoderma Gangrenosum After Reduction Mammoplasty in an Unsuspecting Patient Demographic
by: Natalia A. Pluta, MS, et al.
Published: (2025-01-01)

Pyoderma Gangrenosum and Autoimmune Chronic Active Hepatitis in a 17-Year-Old Female
by: Joanne M. Langley, et al.
Published: (1988-01-01)

Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
by: Ga Hee Jeong, et al.
Published: (2025-01-01)

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation
by: Stephen E. Langabeer, et al.
Published: (2015-01-01)

Pyoderma Gangrenosum: A Review of Clinical Features and Outcomes of 23 Cases Requiring Inpatient Management
by: Mingwei Joel Ye, et al.
Published: (2014-01-01)